Palbociclib After CDK and Endocrine Therapy (PACE)

Running, not enrolling · Phase 2

Conditions studied: Metastatic Breast Cancer

In brief

This research study is studying three combinations of drugs as treatments for breast cancer. The drugs involved in this study are: -Fulvestrant -Fulvestrant with Palbociclib -Fulvestrant with Palbociclib and Avelumab

Key facts

Study ID
NCT03147287
Run by
Dana-Farber Cancer Institute
People needed
220
Starts
2017-09-05
Expected to finish
2026-06-30
Last updated by the study team
2025-09-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.